Literature DB >> 184231

Effect of bromocriptine in pituitary-dependent Cushing's syndrome.

S W Lamberts, J C Birkenhäger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184231     DOI: 10.1677/joe.0.0700315

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


× No keyword cloud information.
  8 in total

1.  Pituitary-dependent Cushing's disease.

Authors:  S P Deacon
Journal:  Br Med J       Date:  1977-05-28

2.  Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine.

Authors:  A B Atkinson; A L Kennedy; B Sheridan
Journal:  Postgrad Med J       Date:  1985-03       Impact factor: 2.401

3.  Management of acute hypercortisolism.

Authors:  N W Thompson; M D Allo
Journal:  World J Surg       Date:  1982-11       Impact factor: 3.352

Review 4.  Pharmacology of bromocriptine in health and disease.

Authors:  A E Mehta; G Tolis
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

5.  Lack of effect of bromocriptine on ACTH levels in patients with bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.

Authors:  N O'Mullane; B Walker; J Jefferson; L Hipkin; M Diver; C Davis
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

6.  Failure of oral bromocriptine to affect hypergastrinemia in two patients with the Zollinger-Ellison syndrome.

Authors:  D F Child; I Laing; P C Ganguli
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

7.  Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro.

Authors:  M Ishibashi; T Yamaji
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

Review 8.  The endocrine profile of bromocriptine: its application in endocrine diseases.

Authors:  I Lancranjan
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.